Skip to main content
OpenTrials

Clinical trial condition

Melanoma

Explore clinical trials studying Melanoma. Study availability and eligibility vary by location and protocol.

1,012 public trials 175 recruiting studies
Refine in advanced search Browse all conditions

Melanoma trial results

Active, Not Recruiting

Effectiveness and Safety of Dabrafenib in Combination With Trametinib as Adjuvant Treatment for Chinese Patients With Stage III BRAF V600 Mutation-positive Melanoma After Complete Resection

NCT04666272

Conditions
Melanoma, Neoplasms, Neoplasms by Histologic Type, +9 more
Locations
  • Novartis Investigative Site Fuzhou, Fujian, China
  • Novartis Investigative Site Zhengzhou, Henan, China
  • Novartis Investigative Site Wuhan, Hubei, China
  • Novartis Investigative Site Changsha, Hunan, China
View Trial Details
Active, Not Recruiting

A Study of Tumor Imaging With Multispectral Optoacoustic Tomography

NCT05488483

Conditions
Breast Cancer, Breast Diseases, Breast Neoplasms, +12 more
Locations
  • Memorial Sloan Kettering Bergen (Consent only ) Montvale, New Jersey, United States
  • Memorial Sloan Kettering Cancer Center @ Suffolk-Commack (Consent only) Commack, New York, United States
  • Memorial Sloan - Kettering Cancer Center New York, United States
  • Helmholtz Institute (Data Analysis Only) Munich, Germany
View Trial Details
Active, Not Recruiting

Analyzing Clinical Outcomes and Genomic Data of American Indian Patient Population

NCT05863052

Conditions
Adenocarcinoma, Bronchial Neoplasms, Carcinoma, +46 more
Locations
  • Arizona Cancer Center at the Unvieristy of Arizona Tucson, Arizona, United States
  • University of New Mexico Comprehensive Cancer Center Albuquerque, New Mexico, United States
  • Stephenson Cancer Center Oklahoma City, Oklahoma, United States
  • Monument Health Cancer Care Institute Rapid City, South Dakota, United States
View Trial Details
Active, Not Recruiting

A Trial to Learn if Fianlimab and Cemiplimab Are Safe and Work Better Than Anti-PD1 Alone in Adult Participants With Resectable Stage 3 or 4 Melanoma

NCT06190951

Conditions
Melanoma, Neoplasms, Neoplasms by Histologic Type, +9 more
Locations
  • UC San Diego La Jolla, California, United States
  • USC Norris Comprehensive Cancer Center Los Angeles, California, United States
  • Hoag Family Cancer Institute Newport Beach, California, United States
  • California Pacific Medical Center Research Institute San Francisco, California, United States
View all 104 locations
View Trial Details
Active, Not Recruiting

Study of Safety and Efficacy of DKY709 Alone or in Combination With PDR001 in Patients With Advanced Solid Tumors.

NCT03891953

Conditions
Breast Diseases, Breast Neoplasms, Bronchial Neoplasms, +33 more
Locations
  • Massachusetts General Hospital Boston, Massachusetts, United States
  • Dana Farber Cancer Institute Boston, Massachusetts, United States
  • Sarah Cannon Research Institute Nashville, Tennessee, United States
  • Novartis Investigative Site Dresden, Saxony, Germany
View Trial Details

Related conditions